Back to Authors

O’Murchu, Brian

A5068218526 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 3

Cardiac atrial natriuretic factor during evolution of congestive heart failure

American Journal of Physiology-Heart and Circulatory Physiology | December 21, 2017 | Volume: 262 | Issue: 4 | Pages: H1248-H1255

10.1152/ajpheart.1992.262.4.h1248 | PMID 1373574

Congestive heart failure (CHF) is a pathophysiological condition associated with increased plasma levels of atrial natriuretic factor (ANF), a peptide hormone of cardiac origin that participates in the homeostatic control of intravascular volume and vascular tone. Atrial myocytes serve as the principal source of ANF under physiological conditions, although recent studies have demonstrated that ventricular myocardium may also synthesize ANF in models of CHF associated with ventricular hypertrophy. The current study was designed to investigate the roles of atrial and ventricular myocardium to synthesize, store, and release ANF during the evolution of tachycardia-induced CHF in the dog. The present study demonstrates a persistent elevation of plasma ANF during the evolution of CHF. In acute CHF (3 h), plasma ANF increased independent of cardiac ANF synthesis. In chronic CHF (15 and 30 days), plasma ANF is maintained by an increase in atrial synthesis and release of the peptide, without recruitment of ventricular ANF synthesis. The present study demonstrates that in acute CHF the increase in plasma ANF is regulated by release of stored peptide, and in chronic CHF the persistent elevation of plasma ANF is maintained by an increase in atrial synthesis of ANF.
Sex Differences in Fractional Flow Reserve-Guided Revascularization: A Nationwide Analysis

Journal of Women's Health | October 18, 2016 | Volume: 26 | Issue: 2 | Pages: 109-115

10.1089/jwh.2016.5806 | PMID 27754754

Adult Congenital Heart Disease

Circulation | June 12, 2012 | Volume: 92 | Issue: 12 | Pages: 3574-3574

10.1161/01.cir.92.12.3574 | PMID 8521581